NFKB1 and non-small cell lung carcinoma: The Cremer group also observed that, despite the activation of NF-kB by TLR7, some pro-inflammatory and angiogenic mediators (IL-1, IL-7, IL-15, IL-12, AGPT4, PDGFβ, AGPT1L) are suppressed in NSCLC cells.